News
-
-
-
PRESS RELEASE
Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product
Jaguar Health, Inc. (NASDAQ:JAGX) announces Napo Pharmaceuticals' participation in the 50th Oncology Nursing Society Congress to showcase Gelclair® for oral mucositis relief in cancer patients -
-
-
-
-
-
PRESS RELEASE
Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules
Jaguar Health, Inc. announces the closing of a private placement, issuing convertible promissory notes and unregistered warrants to selected investors, with gross proceeds of approximately $3.448 million -